Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Obesity, Wiley, Vol. 28, No. 11 ( 2020-11), p. 2049-2055
    Abstract: This study aimed to observe the clinical characteristics of patients with coronavirus disease 2019 (COVID‐19) with overweight and obesity. Methods Consecutive patients with COVID‐19 from 10 hospitals of Jiangsu province, China, were enrolled. Results A total of 297 patients with COVID‐19 were included, and 39.39% and 13.47% of patients had overweight and obesity, respectively. The proportions of bilateral pneumonia (92.50% vs. 73.57%, P  = 0.033) and type 2 diabetes (17.50% vs. 3.57%, P  = 0.006) were higher in patients with obesity than lean patients. The proportions of severe illness in patients with overweight (12.82% vs. 2.86%, P  = 0.006) and obesity (25.00% vs. 2.86%, P   〈  0.001) were significantly higher than lean patients. More patients with obesity developed respiratory failure (20.00% vs. 2.86%, P   〈  0.001) and acute respiratory distress syndrome (5.00% vs. 0%, P  = 0.024) than lean patients. The median days of hospitalization were longer in patients with obesity than lean patients (17.00 days vs. 14.00 days, P  = 0.029). Overweight (OR, 4.222; 95% CI: 1.322‐13.476; P  = 0.015) and obesity (OR, 9.216; 95% CI: 2.581‐32.903; P  = 0.001) were independent risk factors of severe illness. Obesity (HR, 6.607; 95% CI: 1.955‐22.329; P  = 0.002) was an independent risk factor of respiratory failure. Conclusions Overweight and obesity were independent risk factors of severe illness in COVID‐19 patients. More attention should be paid to these patients.
    Type of Medium: Online Resource
    ISSN: 1930-7381 , 1930-739X
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2027211-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages